Pages: ( 1 ) 2

29.11.2007
Congenix launched phase I/IIa study of a novel biological agent (monoclonal antibodies) in patients with rheumatoid arthritis. 6 Moscow sites are participating in this study... more

31.10.2007
Congenix completed phase II study of a novel drug in patients with psoriasis. 9 investigational sites in Moscow, St. Petersburg, Smolensk, Yekaterinburg and other regions of Russia... more

19.06.2007
Starting from the June 18, 2007 the Federal Custom Service resumed biological samples export operation. The export licenses should meet the new requirement of the Service in respect of document package... more